Correlation Between Nanologix and PTC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nanologix and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanologix and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanologix and PTC Therapeutics, you can compare the effects of market volatilities on Nanologix and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanologix with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanologix and PTC Therapeutics.
Diversification Opportunities for Nanologix and PTC Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nanologix and PTC is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Nanologix and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Nanologix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanologix are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Nanologix i.e., Nanologix and PTC Therapeutics go up and down completely randomly.
Pair Corralation between Nanologix and PTC Therapeutics
Given the investment horizon of 90 days Nanologix is expected to generate 38.24 times more return on investment than PTC Therapeutics. However, Nanologix is 38.24 times more volatile than PTC Therapeutics. It trades about 0.16 of its potential returns per unit of risk. PTC Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 0.00 in Nanologix on October 11, 2024 and sell it today you would earn a total of 0.01 from holding Nanologix or generate 9.223372036854776E16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nanologix vs. PTC Therapeutics
Performance |
| Timeline |
| Nanologix |
| PTC Therapeutics |
Nanologix and PTC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nanologix and PTC Therapeutics
The main advantage of trading using opposite Nanologix and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanologix position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.| Nanologix vs. Madrigal Pharmaceuticals | Nanologix vs. Viking Therapeutics | Nanologix vs. Sarepta Therapeutics | Nanologix vs. Hepion Pharmaceuticals |
| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |